Circadian disruption in the pathogenesis of metabolic syndrome

Diabetes and Metabolism

Volumn 40, Issue 5, 2014, Pages 338-346

  Maury, E ^a   Hong, H K ^a   Bass, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Circadian rhythm; Metabolism

Indexed keywords

GLUCOSE; LIPID; TRANSCRIPTION FACTOR CLOCK;

CARDIOVASCULAR FUNCTION; CIRCADIAN RHYTHM; ENERGY HOMEOSTASIS; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; GENETIC MODEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEREDITY; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INFLAMMATION; LIPID METABOLISM; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MOLECULAR CLOCK; NONHUMAN; PATHOGENESIS; REVIEW; SYSTEMATIC REVIEW (TOPIC); BLOOD; CARDIOVASCULAR DISEASE; GENE EXPRESSION REGULATION; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION;

CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; CLOCK PROTEINS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INFLAMMATION; LIPID METABOLISM; LIPIDS; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION;

EID: 84908510371     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.12.005     Document Type: Review

References (121)

1. Eckel R.H., Alberti K.G., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2010, 375:181-183.
2. Emerging Risk Factors Collaboration, Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320.
3. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program-Adult Treatment Panel III. International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13.
4. Alberti K.G., Zimmet P., Shaw J., Group IDFETFC The metabolic syndrome-a new worldwide definition. Lancet 2005, 36:1059-1062.
5. Klein S., Allison D.B., Heymsfield S.B., Kelley D.E., Leibel R.L., Nonas C., et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 2007, 30:1647-1652.
6. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005, 12:295-300.
7. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
8. Wannamethee S.G., Papacosta O., Whincup P.H., Carson C., Thomas M.C., Lawlor D.A., et al. Assessing prediction of diabetes in older adults using different adiposity measures: a 7-year prospective study in 6,923 older men and women. Diabetologia 2010, 53:890-898.
9. Estruch R., Ros E., Salas-Salvado J., Covas M.I., Corella D., Aros F., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368:1279-1290.
10. Scragg R. Vitamin D and type 2 diabetes: are we ready for a prevention trial?. Diabetes 2008, 57:2565-2566.
11. Forouhi N.G., Luan J., Cooper A., Boucher B.J., Wareham N.J. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57:2619-2625.
12. Reis J.P., von Muhlen D., Miller E.R., Michos E.D., Appel L.J. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009, 124:e371-e379.
13. Chacko S.A., Song Y., Manson J.E., Van Horn L., Eaton C., Martin L.W., et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011, 94:209-217.
14. Gagnon C., Lu Z.X., Magliano D.J., Dunstan D.W., Shaw J.E., Zimmet P.Z., et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012, 97:1953-1961.
15. Spiegel K., Tasali E., Leproult R., Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009, 5:253-261.
16. Suwazono Y., Dochi M., Sakata K., Okubo Y., Oishi M., Tanaka K., et al. A longitudinal study on the effect of shift work on weight gain in male Japanese workers. Obesity 2008, 16:1887-1893.
17. Yaggi H.K., Araujo A.B., McKinlay J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006, 29:657-661.
18. Pan A., Schernhammer E.S., Sun Q., Hu F.B. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 2011, 8:e1001141.
19. Kivimaki M., Batty G.D., Hublin C. Shift work as a risk factor for future type 2 diabetes: evidence, mechanisms, implications, and future research directions. PLoS Med 2011, 8:e1001138.
20. Brown D.L., Feskanich D., Sanchez B.N., Rexrode K.M., Schernhammer E.S., Lisabeth L.D. Rotating night shift work and the risk of ischemic stroke. Am J Epidemiol 2009, 169:1370-1377.
21. Janszky I., Ljung R. Shifts to and from daylight saving time and incidence of myocardial infarction. N Engl J Med 2008, 359:1966-1968.
22. Arble D.M., Bass J., Laposky A.D., Vitaterna M.H., Turek F.W. Circadian timing of food intake contributes to weight gain. Obesity 2009, 17:2100-2102.
23. Hatori M., Vollmers C., Zarrinpar A., DiTacchio L., Bushong E.A., Gill S., et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 2012, 15:848-860.
24. Stucchi P., Gil-Ortega M., Merino B., Guzman-Ruiz R., Cano V., Valladolid-Acebes I., et al. Circadian feeding drive of metabolic activity in adipose tissue and not hyperphagia triggers overweight in mice: is there a role of the pentose-phosphate pathway?. Endocrinology 2012, 153:690-699.
25. Masaki T., Chiba S., Yasuda T., Noguchi H., Kakuma T., Watanabe T., et al. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 2004, 53:2250-2260.
26. Salgado-Delgado R., Angeles-Castellanos M., Saderi N., Buijs R.M., Escobar C. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology 2010, 151:1019-1029.
27. Fonken L.K., Workman J.L., Walton J.C., Weil Z.M., Morris J.S., Haim A., et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci U S A 2010, 107:18664-18669.
28. Chen X., McClusky R., Chen J., Beaven S.W., Tontonoz P., Arnold A.P., et al. The number of x chromosomes causes sex differences in adiposity in mice. PLoS Gen 2012, 8:e1002709.
29. Sherman H., Genzer Y., Cohen R., Chapnik N., Madar Z., Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J 2012, 26:3493-3502.
30. Karatsoreos I.N., Bhagat S., Bloss E.B., Morrison J.H., McEwen B.S. Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci U S A 2011, 108:1657-1662.
31. Sensi S., Capani F. Chronobiological aspects of weight loss in obesity: effects of different meal timing regimens. Chronobiol Int 1987, 4:251-261.
32. Scheer F.A., Hilton M.F., Mantzoros C.S., Shea S.A. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009, 106:4453-4458.
33. Garaulet M., Gomez-Abellan P., Alburquerque-Bejar J.J., Lee Y.C., Ordovas J.M., Scheer F.A. Timing of food intake predicts weight loss effectiveness. Int J Obes 2013, 37:604-611.
34. Lowrey P.L., Takahashi J.S. Genetics of circadian rhythms in mammalian model organisms. Adv Genet 2011, 74:175-230.
35. Bass J. Circadian topology of metabolism. Nature 2012, 491:348-356.
36. Hattar S., Lucas R.J., Mrosovsky N., Thompson S., Douglas R.H., Hankins M.W., et al. Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature 2003, 424:76-81.
37. Gerber A., Esnault C., Aubert G., Treisman R., Pralong F., Schibler U. Blood-borne circadian signal stimulates daily oscillations in actin dynamics and SRF activity. Cell 2013, 152:492-503.
38. Okamura H. Suprachiasmatic nucleus clock time in the mammalian circadian system. Cold Spring Harb Symp Quant Biol 2007, 72:551-556.
39. Duffield G.E., Best J.D., Meurers B.H., Bittner A., Loros J.J., Dunlap J.C. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol 2002, 12:551-557.
40. Storch K.F., Lipan O., Leykin I., Viswanathan N., Davis F.C., Wong W.H., et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417:78-83.
41. Ben-Shlomo R., Akhtar R.A., Collins B.H., Judah D.J., Davies R., Kyriacou C.P. Light pulse-induced heme and iron-associated transcripts in mouse brain: a microarray analysis. Chronobiol Int 2005, 22:455-471.
42. Panda S., Antoch M.P., Miller B.H., Su A.I., Schook A.B., Straume M., et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320.
43. Lamia K.A., Storch K.F., Weitz C.J. Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci U S A 2008, 105:15172-15177.
44. Shi S.Q., Ansari T.S., McGuinness O.P., Wasserman D.H., Johnson C.H. Circadian disruption leads to insulin resistance and obesity. Curr Biol 2013, 23:372-381.
45. Bunger M.K., Walisser J.A., Sullivan R., Manley P.A., Moran S.M., Kalscheur V.L., et al. Progressive arthropathy in mice with a targeted disruption of the Mop3/Bmal-1 locus. Genesis 2005, 41:122-132.
46. Rudic R.D., McNamara P., Curtis A.M., Boston R.C., Panda S., Hogenesch J.B., et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004, 2:e377.
47. Curtis A.M., Cheng Y., Kapoor S., Reilly D., Price T.S., Fitzgerald G.A. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A 2007, 104:3450-3455.
48. Anea C.B., Zhang M., Stepp D.W., Simkins G.B., Reed G., Fulton D.J., et al. Vascular disease in mice with a dysfunctional circadian clock. Circulation 2009, 119:1510-1517.
49. Gibbs J.E., Blaikley J., Beesley S., Matthews L., Simpson K.D., Boyce S.H., et al. The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A 2012, 109:582-587.
50. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
51. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
52. Pan X., Zhang Y., Wang L., Hussain M.M. Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. Cell Metab 2010, 12:174-186.
53. Marcheva B., Ramsey K.M., Buhr E.D., Kobayashi Y., Su H., Ko C.H., et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
54. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., et al. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994, 264:719-725.
55. Yang S., Liu A., Weidenhammer A., Cooksey R.C., McClain D., Kim M.K., et al. The role of mPer2 clock gene in glucocorticoid and feeding rhythms. Endocrinology 2009, 150:2153-2160.
56. Zheng B., Larkin D.W., Albrecht U., Sun Z.S., Sage M., Eichele G., et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 1999, 400:169-173.
57. Zhang E.E., Liu Y., Dentin R., Pongsawakul P.Y., Liu A.C., Hirota T., et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med 2010, 16:1152-1156.
58. Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H., Jonker J.W., et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 2011, 480:552-556.
59. Narasimamurthy R., Hatori M., Nayak S.K., Liu F., Panda S., Verma I.M. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 2012, 109:12662-12667.
60. Doi M., Takahashi Y., Komatsu R., Yamazaki F., Yamada H., Haraguchi S., et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010, 16:67-74.
61. van der Horst G.T., Muijtjens M., Kobayashi K., Takano R., Kanno S., Takao M., et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999, 398:627-630.
62. Vitaterna M.H., Selby C.P., Todo T., Niwa H., Thompson C., Fruechte E.M., et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci U S A 1999, 96:12114-12119.
63. Paschos G.K., Ibrahim S., Song W.L., Kunieda T., Grant G., Reyes T.M., et al. Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med 2012, 18:1768-1777.
64. Sadacca L.A., Lamia K.A., deLemos A.S., Blum B., Weitz C.J. An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia 2011, 54:120-124.
65. Lee J., Moulik M., Fang Z., Saha P., Zou F., Xu Y., et al. Bmal1 and beta-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced beta-cell failure in mice. Mol Cell Biol 2013, 33:2327-2338.
66. Nguyen K.D., Fentress S.J., Qiu Y., Yun K., Cox J.S., Chawla A. Circadian gene bmal1 regulates diurnal oscillations of Ly6Chi inflammatory monocytes. Science 2013, 341(6153):1483-1488.
67. Le Martelot G., Claudel T., Gatfield D., Schaad O., Kornmann B., Lo Sasso G., et al. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol 2009, 7:e100081.
68. Duez H., van der Veen J.N., Duhem C., Pourcet B., Touvier T., Fontaine C., et al. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology 2008, 135:689-698.
69. Woldt E., Sebti Y., Solt L.A., Duhem C., Lancel S., Eeckhoute J., et al. Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med 2013, 19:1039-1046.
70. Cho H., Zhao X., Hatori M., Yu R.T., Barish G.D., Lam M.T., et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature 2012, 485:123-127.
71. McDearmon E.L., Patel K.N., Ko C.H., Walisser J.A., Schook A.C., Chong J.L., et al. Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science 2006, 314:1304-1308.
72. Andrews J.L., Zhang X., McCarthy J.J., McDearmon E.L., Hornberger T.A., Russell B., et al. CLOCK and BMAL1 regulate MyoD and are necessary for maintenance of skeletal muscle phenotype and function. Proc Natl Acad Sci U S A 2010, 107:19090-19095.
73. Oishi K., Atsumi G., Sugiyama S., Kodomari I., Kasamatsu M., Machida K., et al. Disrupted fat absorption attenuates obesity induced by a high-fat diet in Clock mutant mice. FEBS Lett 2006, 580:127-130.
74. Kennaway D.J., Voultsios A., Varcoe T.J., Moyer R.W. Melatonin and activity rhythm responses to light pulses in mice with the Clock mutation. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1231-R1240.
75. Scott E.M., Carter A.M., Grant P.J. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes 2008, 32:658-662.
76. Sookoian S., Gemma C., Gianotti T.F., Burgueno A., Castano G., Pirola C.J. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr 2008, 87:1606-1615.
77. Garaulet M., Corbalan-Tutau M.D., Madrid J.A., Baraza J.C., Parnell L.D., Lee Y.C., et al. PERIOD2 variants are associated with abdominal obesity, psycho-behavioral factors, and attrition in the dietary treatment of obesity. J Am Diet Assoc 2010, 110:917-921.
78. Gomez-Abellan P., Gomez-Santos C., Madrid J.A., Milagro F.I., Campion J., Martinez J.A., et al. Circadian expression of adiponectin and its receptors in human adipose tissue. Endocrinology 2010, 151:115-122.
79. Licinio J., Negrao A.B., Mantzoros C., Kaklamani V., Wong M.L., Bongiorno P.B., et al. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A 1998, 95:2541-2546.
80. Shimba S., Ishii N., Ohta Y., Ohno T., Watabe Y., Hayashi M., et al. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci U S A 2005, 102:12071-12076.
81. Shostak A., Meyer-Kovac J., Oster H. Circadian regulation of lipid mobilization in white adipose tissues. Diabetes 2013, 62:2195-2203.
82. Hussain M.M., Pan X. Clock regulation of dietary lipid absorption. Curr Opin Clin Nutr Metab Care 2012, 15:336-341.
83. Pan X., Hussain M.M. Clock is important for food and circadian regulation of macronutrient absorption in mice. J Lipid Res 2009, 50:1800-1813.
84. Feng D., Liu T., Sun Z., Bugge A., Mullican S.E., Alenghat T., et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331:1315-1319.
85. Sun Z., Miller R.A., Patel R.T., Chen J., Dhir R., Wang H., et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med 2012, 18:934-942.
86. Solt L.A., Wang Y., Banerjee S., Hughes T., Kojetin D.J., Lundasen T., et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012, 485:62-68.
87. la Fleur S.E., Kalsbeek A., Wortel J., Fekkes M.L., Buijs R.M. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001, 50:1237-1243.
88. Kalsbeek A., Yi C.X., La Fleur S.E., Fliers E. The hypothalamic clock and its control of glucose homeostasis. Trends Endocrinol Metab 2010, 21:402-410.
89. Boden G., Ruiz J., Urbain J.L., Chen X. Evidence for a circadian rhythm of insulin secretion. Am J Physiol 1996, 271(2 Pt 1):E246-E252.
90. Feneberg R., Lemmer B. Circadian rhythm of glucose uptake in cultures of skeletal muscle cells and adipocytes in Wistar-Kyoto, Wistar, Goto-Kakizaki, and spontaneously hypertensive rats. Chronobiol Int 2004, 21:521-538.
91. Hirota T., Lee J.W., St John P.C., Sawa M., Iwaisako K., Noguchi T., et al. Identification of small molecule activators of cryptochrome. Science 2012, 337:1094-1097.
92. Dupuis J., Langenberg C., Prokopenko I., Saxena R., Soranzo N., Jackson A.U., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42:105-116.
93. Englund A., Kovanen L., Saarikoski S.T., Haukka J., Reunanen A., Aromaa A., et al. NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms 2009, 7:5.
94. Garaulet M., Lee Y.C., Shen J., Parnell L.D., Arnett D.K., Tsai M.Y., et al. CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am J Clin Nutr 2009, 90:1466-1475.
95. Arjona A., Silver A.C., Walker W.E., Fikrig E. Immunity's fourth dimension: approaching the circadian-immune connection. Trends Immunol 2012, 33:607-612.
96. Keller M., Mazuch J., Abraham U., Eom G.D., Herzog E.D., Volk H.D., et al. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci U S A 2009, 106:21407-21412.
97. Lam M.T., Cho H., Lesch H.P., Gosselin D., Heinz S., Tanaka-Oishi Y., et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-515.
98. Mukherji A., Kobiita A., Ye T., Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013, 153:812-827.
99. Spengler M.L., Kuropatwinski K.K., Comas M., Gasparian A.V., Fedtsova N., Gleiberman A.S., et al. Core circadian protein CLOCK is a positive regulator of NF-kappaB-mediated transcription. Proc Natl Acad Sci U S A 2012, 109:E2457-E2465.
100. Bellet M.M., Deriu E., Liu J.Z., Grimaldi B., Blaschitz C., Zeller M., et al. Circadian clock regulates the host response to Salmonella. Proc Natl Acad Sci U S A 2013, 110:9897-9902.
101. Baker R.G., Hayden M.S., Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab 2011, 13:11-22.
102. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
103. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135:61-73.
104. Durgan D.J., Young M.E. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 2010, 106:647-658.
105. Zuber A.M., Centeno G., Pradervand S., Nikolaeva S., Maquelin L., Cardinaux L., et al. Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci U S A 2009, 106:16523-16528.
106. Doi M., Ishida A., Miyake A., Sato M., Komatsu R., Yamazaki F., et al. Circadian regulation of intracellular G-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus. Nat Commun 2011, 2:327.
107. Bray M.S., Shaw C.A., Moore M.W., Garcia R.A., Zanquetta M.M., Durgan D.J., et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiology Heart Circ Physiol 2008, 294:H1036-H1047.
108. Wang N., Yang G., Jia Z., Zhang H., Aoyagi T., Soodvilai S., et al. Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab 2008, 8:482-491.
109. Gumz M.L., Stow L.R., Lynch I.J., Greenlee M.M., Rudin A., Cain B.D., et al. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest 2009, 119:2423-2434.
110. Anea C.B., Cheng B., Sharma S., Kumar S., Caldwell R.W., Yao L., et al. Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice. Circ Res 2012, 111:1157-1165.
111. Vaughan D.E. PAI-1 and atherothrombosis. J Thromb Haemost 2005, 3:1879-1883.
112. Westgate E.J., Cheng Y., Reilly D.F., Price T.S., Walisser J.A., Bradfield C.A., et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation 2008, 117:2087-2095.
113. Lupia E., Goffi A., Bosco O., Montrucchio G. Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm 2012, 2012:3908-3992.
114. Maury E., Brichard S.M., Pataky Z., Carpentier A., Golay A., Bobbioni-Harsch E. Effect of obesity on growth-related oncogene factor-alpha, thrombopoietin, and tissue inhibitor metalloproteinase-1 serum levels. Obesity 2010, 18:1503-1509.
115. Tracey C.J., Pan X., Catterson J.H., Harmar A.J., Hussain M.M., Hartley P.S. Diurnal expression of the thrombopoietin gene is regulated by CLOCK. J Thromb Haemost 2012, 10:662-669.
116. Woon P.Y., Kaisaki P.J., Braganca J., Bihoreau M.T., Levy J.C., Farrall M., et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A 2007, 104:14412-14417.
117. Dallmann R., Viola A.U., Tarokh L., Cajochen C., Brown S.A. The human circadian metabolome. Proc Natl Acad Sci U S A 2012, 109:2625-2629.
118. Moller-Levet C.S., Archer S.N., Bucca G., Laing E.E., Slak A., Kabiljo R., et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A 2013, 110:E1132-E1141.
119. Peek C.B., Ramsey K.M., Marcheva B., Bass J. Nutrient sensing and the circadian clock. Trends Endocrinol Metab 2012, 23:312-318.
120. Kohsaka A., Laposky A.D., Ramsey K.M., Estrada C., Joshu C., Kobayashi Y., et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007, 6:414-421.
121. Prasai M.J., Mughal R.S., Wheatcroft S.B., Kearney M.T., Grant P.J., Scott E.M. Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm. Diabetes 2013, 62:1981-1989.